# EDGAR Filing Document

**Accession Number:** 0001736297
**File Stem:** 0001736297-25-000064
**Filing Date:** 2025-6
**Character Count:** 18910
**Document Hash:** 5b9798be3da3454b82a9ac7f9ec97ab5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001736297-25-000064.hdr.sgml**: 20250618

**ACCESSION NUMBER**: 0001736297-25-000064

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 5

**FILED AS OF DATE**: 20250618

**DATE AS OF CHANGE**: 20250618

**EFFECTIVENESS DATE**: 20250618

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Astera Labs, Inc.
- **CENTRAL INDEX KEY:** 0001736297
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 823437062
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-288144
- **FILM NUMBER:** 251056993

**BUSINESS ADDRESS:**
- **STREET 1:** 2345 NORTH FIRST STREET
- **CITY:** SAN JOSE
- **STATE:** CA
- **ZIP:** 95131
- **BUSINESS PHONE:** 408-242-7319

**MAIL ADDRESS:**
- **STREET 1:** 2345 NORTH FIRST STREET
- **CITY:** SAN JOSE
- **STATE:** CA
- **ZIP:** 95131

**As filed with the U.S. Securities and Exchange Commission on June 18, 2025** 

**Registration No. 333-** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

**FORM S-8** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933*** 

**Astera Labs, Inc.** 

**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Delaware** | **82-3437062** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer**<br>**Identification No.)** |
| **2345 North First Street**<br>**San Jose, CA** | **95131** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**2024 Stock Option and Incentive Plan** 

**2024 Employee Stock Purchase Plan** 

**(Full titles of the plans)** 

**Jitendra Mohan** 

**Co-Founder and Chief Executive Officer** 

**Astera Labs, Inc.** 

**2345 North First Street**

**San Jose, CA 95131**

**(Name and address of agent for service)** 

**(408) 766-3806** 

**(Telephone number, including area code, of agent for service)** 

***Copies to:***

---

| | |
|:---|:---|
| **Bradley C. Weber**<br>**Julia R. White**<br>**Goodwin Procter LLP**<br>**601 Marshall Street**<br>**Redwood City, CA 94063**<br>**(650) 752-3100** | **Philip T. Mazzara**<br>**General Counsel & Secretary**<br>**Astera Labs, Inc.**<br>**2345 North First Street**<br>**San Jose, CA 95131**<br>**(408) 766-3806** |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

------

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE**

This Registration Statement on Form S-8 is being filed by Astera Labs, Inc. (the "Company") for the purpose of registering an additional 8,100,874 shares of its common stock, par value $0.0001 per share ("Common Stock"), that have become available for issuance pursuant to the Astera Labs, Inc. 2024 Stock Option and Incentive Plan ("2024 Plan") and an additional 1,620,174 shares of Common Stock that have become available for issuance pursuant to the Astera Labs, Inc. 2024 Employee Stock Purchase Plan ("2024 ESPP"). These shares are securities of the same class as other securities for which a registration statement on Form S-8 was filed with the U.S. Securities and Exchange Commission (the "Commission") on March 20, 2024 (<u>[Commission File No.](https://www.sec.gov/Archives/edgar/data/1736297/000119312524071814/d787818ds8.htm)[333-278078](https://www.sec.gov/Archives/edgar/data/1736297/000119312524071814/d787818ds8.htm)</u>) (the "Prior Registration Statement").

This Registration Statement is submitted in accordance with General Instruction E to Form S-8 regarding the Registration of Additional Securities. Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statement, to the extent relating to the registration of the Common Stock issuable under the 2024 Plan and the 2024 ESPP, are incorporated herein by reference and made part of this Registration Statement, except as otherwise amended, updated or supplemented herein.

------

**PART II** 

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT** 

Item 3. <u>Incorporation of Documents by Reference</u>.

The following documents filed with the Commission are hereby incorporated by reference in this prospectus:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Company's Annual Report on <u>[Form 10-K](https://www.sec.gov/Archives/edgar/data/1736297/000173629725000003/alab-20241231.htm)</u>, filed with the Commission on February 14, 2025 (File No. 001-41979).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Company's Quarterly Report on <u>[Form 10-Q](https://www.sec.gov/Archives/edgar/data/1736297/000173629725000031/alab-20250331.htm)</u>, filed with the Commission on May 7, 2025 (File No. 001-41979).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Company's Current Reports on Form 8-K filed with the Commission on <u>[March 3, 2025](https://www.sec.gov/Archives/edgar/data/1736297/000173629725000018/alab-20250302.htm)</u> (File No. 001-41979) and <u>[June 10, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001736297/000173629725000051/alab-20250605.htm)</u> (File No. 001-41979).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)The description of the Company's common stock contained in the Company's Registration Statement on <u>[Form 8-A](https://www.sec.gov/Archives/edgar/data/1736297/000119312524069129/d750302d8a12b.htm)</u> (File No. 001-41979) filed with the Commission on March 15, 2024 under Section 12(b) of the Exchange Act, including any amendments or reports filed for the purpose of updating such description.

All documents subsequently filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment to the Registration Statement which indicates that all of the shares registered hereunder have been sold or which deregisters all of such shares then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the respective dates of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with Commission rules shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein, or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein, modifies or supersedes such earlier statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

------

Item 8. <u>Exhibits</u>.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** |
|<br>**Exhibit Number** |<br>**Exhibit Title** | **Form** | **File No.** | **Exhibit** | **Filing** <br>**Date** | **Filed** <br>**Herewith** |
| 4.1 | <u>[Amended and Restated Certificate of Incorporation of the Registrant](https://www.sec.gov/Archives/edgar/data/1736297/000119312524080594/d800855dex31.htm)</u> | 8-K | 001-41979 | 3.1 | 3/28/2024 |  |
| 4.2 | <u>[Second Amended and Restated Bylaws of the Registrant](https://www.sec.gov/Archives/edgar/data/1736297/000119312524080594/d800855dex32.htm)</u> | 8-K | 001-41979 | 3.2 | 3/28/2024 |  |
| 4.3 | <u>[Form of common stock certificate of the Registrant](https://www.sec.gov/Archives/edgar/data/1736297/000119312524062817/d285484dex41.htm)</u> | S-1/A | 333-277205 | 4.1 | 3/8/2024 |  |
| 5.1 | <u>[Opinion of Goodwin Procter LLP](a06182025forms-8xex51x232.htm)</u> |  |  |  |  | X |
| 23.1 | <u>[Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm](a06182025forms-8xex231.htm)</u> |  |  |  |  | X |
| 23.2 | <u>[Consent of Goodwin Procter LLP (included in Exhibit 5.1)](a06182025forms-8xex51x232.htm)</u> |  |  |  |  | X |
| 24.1 | <u>[Power of Attorney (contained on signature page hereto)](#i1584a21353394d81b239d74acc58c24c_13)</u> |  |  |  |  | X |
| 99.1 | <u>[2024 Stock Option and Incentive Plan, and forms of award agreements thereunder](https://www.sec.gov/Archives/edgar/data/0001736297/000173629724000006/exhibit102.htm)</u> | 10-Q | 001-41979 | 10.2 | 5/8/2024 |  |
| 99.2 | <u>[2024 Employee Stock Purchase Plan](https://www.sec.gov/Archives/edgar/data/0001736297/000173629724000006/exhibit103.htm)</u> | 10-Q | 001-41979 | 10.3 | 5/8/2024 |  |
| 107 | <u>[Filing Fee Table](a06182025forms-8xex107fili.htm)</u> |  |  |  |  | X |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Santa Clara, California, on June 18, 2025.

---

| | | |
|:---|:---|:---|
| | **ASTERA LABS, INC.** | **ASTERA LABS, INC.** |
| Date: June 18, 2025 | By: | /s/ Jitendra Mohan |
|  | Name: | Jitendra Mohan |
|  | Title: | Chief Executive Officer  |

---

**POWER OF ATTORNEY AND SIGNATURES**

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Jitendra Mohan, Michael Tate, and Philip Mazzara, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign the Registration Statement on Form S-8 of Astera Labs, Inc., and any or all amendments (including post-effective amendments), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite or necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Jitendra Mohan | Co-Founder, Chief Executive Officer, and Director | June 18, 2025 |
| Jitendra Mohan | (*Principal Executive Officer*) |  |
| /s/ Michael Tate | Chief Financial Officer | June 18, 2025 |
| Michael Tate | (*Principal Financial Officer*) |  |
| /s/ Manuel Alba | Chair of the Board | June 18, 2025 |
| Manuel Alba |  |  |
| /s/ Craig Barratt | Director | June 18, 2025 |
| Craig Barratt |  |  |
| /s/ Stefan Dyckerhoff | Director | June 18, 2025 |
| Stefan Dyckerhoff |  |  |
| /s/ Sanjay Gajendra | Co-Founder, President, Chief Operating Officer, and Director | June 18, 2025 |
| Sanjay Gajendra |  |  |
| /s/ Michael Hurlston | Director | June 18, 2025 |
| Michael Hurlston |  |  |
| /s/ Jack Lazar | Director | June 18, 2025 |
| Jack Lazar |  |  |
| /s/ Bethany Mayer | Director | June 18, 2025 |
| Bethany Mayer |  |  |

---

## Ex-Filing

**Exhibit 107**

**Calculation of Filing Fee Tables**

**Form S-8**

(Form Type)

**Astera Labs, Inc.**

(Exact Name of Registrant as Specified in its Charter)

<u>Table 1: Newly Registered Securities</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Fee Calculation Rule** | **Amount Registered**<sup>(1)</sup> | **Proposed Maximum Offering Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | Common Stock, $0.0001 par value per share | Rule 457(c) and Rule 457(h) | 8100874<sup>(2)</sup>  | $91.75<sup>(3</sup><sup>)</sup> | $743255189.50  | 0.0001531 | $113792.37 |
| Equity | Common Stock, $0.0001 par value per share | Rule 457(c) and Rule 457(h) | 1620174<sup>(4)</sup> | $77.99<sup>(</sup><sup>5</sup><sup>)</sup> | $126357370.26 | 0.0001531 | $19345.31 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  | $869612559.76 |  | $133137.68 |
| **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** |  |  |  |  |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  |  |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  | $133137.68 |

---

------

<sup>(1)</sup> Pursuant to Rule 416 of the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of the Registrant's common stock, par value $0.0001 per share ("Common Stock"), that become issuable under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan ("2024 Plan") and the Astera Labs, Inc. 2024 Employee Stock Purchase Plan ("2024 ESPP") by reason of any stock dividend, stock split, recapitalization or other similar transaction that increases the number of outstanding shares of Common Stock.

<sup>(2)</sup> Represents an automatic annual increase equal to 5.0% of the total number of shares of the Registrant's Common Stock outstanding on December 31 of the preceding year, which annual increase is provided by the 2024 Plan.

<sup>(3)</sup> Estimated in accordance with Rule 457(c) and Rule 457(h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $91.75 per share, which is the average of the high and low prices of the Registrant's Common Stock on June 13, 2025, as reported on the Nasdaq Global Select Market.

<sup>(4)</sup> Represents an automatic increase equal to 1.0% of the total number of shares of the Registrant's Common Stock outstanding on December 31 of the preceding year, which annual increase is provided by the 2024 ESPP.

<sup>(5)</sup> Estimated in accordance with Rule 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $91.75 per share, which is the average of the high and low prices of the Registrant's Common Stock on June 13, 2025, as reported on the Nasdaq Global Select Market, multiplied by 85%. Pursuant to the 2024 ESPP, the purchase price of Common Stock reserved for issuance thereunder will be 85% of the Fair Market Value (as defined in the 2024 ESPP) of the Common Stock on the Offering Date (as defined in the 2024 ESPP) or the Exercise Date (as defined in the 2024 ESPP), whichever is less.

## Exhibit 5.1

**Exhibit 5.1**

---

| | |
|:---|:---|
| ![image_0a.jpg](image_0a.jpg) | Goodwin Procter LLP<br>601 Marshall Street<br>Redwood City, CA 94063<br>goodwinlaw.com<br>+1 650 752 3100 |

---

June 18, 2025

Astera Labs, Inc.

2345 North First Street

San Jose, CA 95131

Re:&nbsp;&nbsp;&nbsp;&nbsp;<u>Securities Being Registered under Registration Statement on Form S-8</u>

We have acted as counsel to you in connection with your filing of a Registration Statement on Form S-8 (the "Registration Statement") pursuant to the Securities Act of 1933, as amended (the "Securities Act"), on or about the date hereof relating to an aggregate of 9,721,048 shares (the "Shares") of common stock, $0.0001 par value per share (the "Common Stock"), of Astera Labs, Inc., a Delaware corporation (the "Company"), consisting of (a) 8,100,874 Shares that may be issued pursuant to the Company's 2024 Stock Option and Incentive Plan (the "2024 Plan") and (b) 1,620,174 Shares that may be issued pursuant to the Company's 2024 Employee Stock Purchase Plan (together with the 2024 Plan, the "Plans").

We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinion set forth below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinion set forth below, on certificates of officers of the Company.

For purposes of the opinion set forth below, we have assumed that, at the time Shares are issued, the total number of then unissued Shares, when added to the number of shares of Common Stock issued, subscribed for, or otherwise committed to be issued, does not exceed the number of shares of Common Stock authorized by the Company's certificate of incorporation.

The opinion set forth below is limited to the Delaware General Corporation Law.

Based on the foregoing, we are of the opinion that the Shares have been duly authorized and, when delivered against payment therefor in accordance with the terms of the Plans, will be validly issued, fully paid and nonassessable.

This opinion letter and the opinion it contains shall be interpreted in accordance with the Core Opinion Principles as published in 74 *Business Lawyer* 815 (Summer 2019).

---

| |
|:---|
| Very truly yours, |
| /s/ Goodwin Procter LLP |
| GOODWIN PROCTER LLP |

---

## Exhibit 23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Astera Labs, Inc. of our report dated February 13, 2025 relating to the financial statements, which appears in Astera Labs, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2024.

/s/ PricewaterhouseCoopers LLP

Seattle, Washington

June 18, 2025

<br>